Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Companyโs technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the userโs mobile device.
์ข
๋ชฉ ์ฝ๋ CODX
ํ์ฌ ์ด๋ฆCo-Diagnostics Inc
์์ฅ์ผJul 12, 2017
CEOEgan (Dwight H)
์ง์ ์132
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃJul 12
์ฃผ์2401 S. Foothill Dr. Suite D
๋์SALT LAKE CITY
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ84109
์ ํ18014381036
์น์ฌ์ดํธhttps://codiagnostics.com/
์ข
๋ชฉ ์ฝ๋ CODX
์์ฅ์ผJul 12, 2017
CEOEgan (Dwight H)